Raybow PharmaScience is the CDMO division of Zhejiang Jiuzhou Pharmaceutical Co., Ltd, (Abbr. Jiuzhou Pharma, Stock code 603456), a major API supplier to large pharmaceutical companies across the globe that was founded in the 1970’s. Raybow was founded in 2008 to handle contract business for innovator companies and it covers discovery support through commercial manufacturing for small molecule therapeutics on behalf of our clients worldwide. The emphasis is on efficient and close collaborative development activities for pharmaceutical organizations.
Throughout the history of the organization, Raybow has focused on targeted growth in scientific achievement to ensure that our customers receive first in class technological contributions to create safe and effective pharmaceutical products. Our stewardship of the environment is a core value, reflected in the Raybow logo (light blue for sky, green for earth, dark blue for ocean) and in our many accolades for sustainability. Green chemistry is a key technical component of our projects.
Regulatory authorities have awarded commendations for our quality and environmental care. Clients have rewarded us with repeat business for decades. We have helped commercially launch four client products that started at pre-clinical, one of which is now a blockbuster drug.
3 R&D Sites (Taizhou, Hangzhou, North Carolina)
3 FDA Inspected Sites (Taizhou, Suzhou, North Carolina)